VIVEbiotech

ith 10 years of experience and more than 180 batches manufactured in bioreactor, half of them in the last 3 years, we bring proven consistency, regulatory compliance, and deep scientific know-how.

Serving global clients—US, Europe, Asia, and Australia—we deliver high-quality, cost-effective vectors that meet both FDA and EMA standards.

Our approach enables clients to advance their programs confidently, without constraints from proprietary systems or complex licensing landscapes.

We support projects from early-stage optimization through commercial scale, using a robust, adherent-based plug-and-play platform, offering end-to-end solutions that support projects with tailored approaches across all vector generations and pseudotypes.